Female Genital Mutilation/Cutting: Understanding the Ongoing Global Crisis
Female genital mutilation (FGM) is defined by the World Health Organization (WHO) as ‘all procedures which intentionally alter or damage the external female genitalia organs for non-medical reasons and which have no benefit for the health of young girls and women.’...
March 2025 Newsletter: Pharmalys takes over full management of the GCLP Accreditation Scheme, Corporate Social Responsibility
Pharmalys is pleased to announce that, effective from 2025, we have taken on the full management of the Good Clinical Laboratory Practice (GCLP) Accreditation Scheme, which we have co-managed with Tim Stiles of Qualogy 2002 Ltd for the past two years. This marks an...
May 2025 Newsletter: Senegal Achieves WHO Maturity Level 3, Improving Patient Understanding in Informed Consent, LEAP Africa and Mastercard Foundation Visit Pharmalys
Senegal Leads the Way: First Francophone African Country to Achieve WHO Maturity Level 3! We are thrilled to celebrate a significant achievement in global health and pharmaceutical innovation: Senegal has become the first Francophone country – and seventh country...
January 2025 Newsletter: Highlights from the CREDO Webinar, Pharmalys Team Training 2024, World Neglected Tropical Diseases Day
Dear all, We are pleased to kick off the new year by sharing the video recording and key information from the CREDO webinar we organised on Implementation Research at the end of last year. With 287 registrations, the event underscored the strong interest from...